{"id":29575,"date":"2024-07-03T09:36:35","date_gmt":"2024-07-03T08:36:35","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/?p=29575"},"modified":"2024-07-18T14:57:13","modified_gmt":"2024-07-18T13:57:13","slug":"promise-weekly-digest-nr-21","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/promise-weekly-digest-nr-21\/","title":{"rendered":"PROMISE Weekly Digest Nr 21"},"content":{"rendered":"\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\"  class=\"wp-block-file__embed\" data=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2024\/07\/20240628-Weekly-Digest-Nr-21-Week-26-1.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of 20240628-Weekly-Digest-Nr-21-Week-26-1.\"><\/object><a id=\"wp-block-file--media-71b78d04-3479-42ab-92a9-165a56cfa57d\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2024\/07\/20240628-Weekly-Digest-Nr-21-Week-26-1.pdf\">20240628-Weekly-Digest-Nr-21-Week-26-1<\/a><a href=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2024\/07\/20240628-Weekly-Digest-Nr-21-Week-26-1.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-71b78d04-3479-42ab-92a9-165a56cfa57d\">T\u00e9l\u00e9charger<\/a><\/div>\n\n\n\n<p><em><span style=\"text-decoration: underline;\"><strong>English version below<\/strong><\/span><\/em><\/p>\n\n\n\n<p>Au c\u0153ur d\u2019un r\u00e9seau national et europ\u00e9en de partenaires, l\u2019UMR 1092 RESINFIT recueille un flux permanent d\u2019actualit\u00e9s&nbsp;sur la r\u00e9sistance aux antimicrobiens, l\u2019approche globale One Health et sur les th\u00e9matiques associ\u00e9es. Weekly Digest est l\u2019outil de diffusion de cette veille, disponible sous forme d\u2019une lettre \u00e9lectronique hebdomadaire en anglais. <\/p>\n\n\n\n<p>Weekly Digest traite des actualit\u00e9s informatives, techniques, juridiques et administratives (politique de sant\u00e9, publications scientifiques, sant\u00e9 publique, conf\u00e9rences et webinaires, publications sur les appels d\u2019offres, etc.) en Europe. En quelques lignes, il pr\u00e9sente les informations pertinentes.<\/p>\n\n\n\n<p><br><strong>Pourquoi recevez-vous cette newsletter ?<\/strong> En tant que partenaires impliqu\u00e9es dans les projets de l&#8217;UMR 1092 RESINFIT (RaDAR, PROMISE, EU-JAMRAI), vous \u00eates dans la liste de diffusion de cette nouvelle lettre d&#8217;actualit\u00e9s.<\/p>\n\n\n\n<p>Si vous souhaitez vous d\u00e9sabonner, n&#8217;h\u00e9sitez pas \u00e0 vous rendre sur <a href=\"https:\/\/www.unilim.fr\/resinfit\/weekly-digest\/\">cette page<\/a>. Le lien est aussi disponible en bas de chaque newsletter.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p>At the heart of a national and European network of partners, INSERM&#8217;s RESINFIT joint research unit 1092 gathers a permanent flow of news focusing on antimicrobial resistance (AMR) and other One Health-related topics.<\/p>\n\n\n\n<p>This AMR Weekly Digest is the tool used to disseminate this monitoring, available in the form of a weekly electronic newsletter. This Weekly Digest covers AMR-related information from research findings, scientific events, public health reports, policy briefs, legislation and procurement mainly in Europe. In just a few lines, it presents the relevant news with the publicly available sources.<\/p>\n\n\n\n<p><br><strong>Why are you receiving this newsletter?<\/strong> As partners involved in UMR 1092 RESINFIT projects (RaDAR, PROMISE, EU-JAMRAI), you are on the mailing list for this new newsletter.<\/p>\n\n\n\n<p>If you wish to unsubscribe, please go to <a href=\"https:\/\/www.unilim.fr\/resinfit\/weekly-digest\/\">this page<\/a>. The link is also available at the bottom of each newsletter.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>English version below Au c\u0153ur d\u2019un r\u00e9seau national et europ\u00e9en de partenaires, l\u2019UMR 1092 RESINFIT recueille un flux permanent d\u2019actualit\u00e9s&nbsp;sur la r\u00e9sistance aux antimicrobiens, l\u2019approche globale One Health et sur les th\u00e9matiques associ\u00e9es. Weekly Digest est l\u2019outil de diffusion de cette veille, disponible sous forme d\u2019une lettre \u00e9lectronique hebdomadaire en anglais. Weekly Digest traite des [&hellip;]<\/p>\n","protected":false},"author":280,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[31,41,37],"tags":[6697,6607,6700,6621,6615],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>PROMISE Weekly Digest Nr 21 - French\u00a0National ANTIBIOTIC RESISTANCE Portal<\/title>\n<meta name=\"description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/promise-weekly-digest-nr-21\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PROMISE Weekly Digest Nr 21 - French\u00a0National ANTIBIOTIC RESISTANCE Portal\" \/>\n<meta property=\"og:description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/promise-weekly-digest-nr-21\/\" \/>\n<meta property=\"og:site_name\" content=\"French\u00a0National ANTIBIOTIC RESISTANCE Portal\" \/>\n<meta property=\"article:published_time\" content=\"2024-07-03T08:36:35+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-07-18T13:57:13+00:00\" \/>\n<meta name=\"author\" content=\"Kevin Gr\u00e9goire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Kevin Gr\u00e9goire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/promise-weekly-digest-nr-21\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/promise-weekly-digest-nr-21\/\"},\"author\":{\"name\":\"Kevin Gr\u00e9goire\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/3bec06f8a90e180a3ba8957cae88c700\"},\"headline\":\"PROMISE Weekly Digest Nr 21\",\"datePublished\":\"2024-07-03T08:36:35+00:00\",\"dateModified\":\"2024-07-18T13:57:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/promise-weekly-digest-nr-21\/\"},\"wordCount\":308,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\"},\"keywords\":[\"AMR\",\"Antibior\u00e9sistance\",\"Antimicrobioal Resistance\",\"OneHealth\",\"PROMISE\"],\"articleSection\":[\"Actualit\u00e9s\",\"Actualit\u00e9s PPR Antibior\u00e9sistance\",\"Bilans, rapports et recommandations\"],\"inLanguage\":\"en-GB\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/promise-weekly-digest-nr-21\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/promise-weekly-digest-nr-21\/\",\"name\":\"PROMISE Weekly Digest Nr 21 - French\u00a0National ANTIBIOTIC RESISTANCE Portal\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website\"},\"datePublished\":\"2024-07-03T08:36:35+00:00\",\"dateModified\":\"2024-07-18T13:57:13+00:00\",\"description\":\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/promise-weekly-digest-nr-21\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/promise-weekly-digest-nr-21\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/promise-weekly-digest-nr-21\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Practical info &amp; communications\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"News\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"PROMISE Weekly Digest Nr 21\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\",\"name\":\"French\u00a0National ANTIBIOTIC RESISTANCE Portal\",\"description\":\"INSERM - From science to health\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/3bec06f8a90e180a3ba8957cae88c700\",\"name\":\"Kevin Gr\u00e9goire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PROMISE Weekly Digest Nr 21 - French\u00a0National ANTIBIOTIC RESISTANCE Portal","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/promise-weekly-digest-nr-21\/","og_locale":"en_GB","og_type":"article","og_title":"PROMISE Weekly Digest Nr 21 - French\u00a0National ANTIBIOTIC RESISTANCE Portal","og_description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/promise-weekly-digest-nr-21\/","og_site_name":"French\u00a0National ANTIBIOTIC RESISTANCE Portal","article_published_time":"2024-07-03T08:36:35+00:00","article_modified_time":"2024-07-18T13:57:13+00:00","author":"Kevin Gr\u00e9goire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Kevin Gr\u00e9goire","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/promise-weekly-digest-nr-21\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/promise-weekly-digest-nr-21\/"},"author":{"name":"Kevin Gr\u00e9goire","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/3bec06f8a90e180a3ba8957cae88c700"},"headline":"PROMISE Weekly Digest Nr 21","datePublished":"2024-07-03T08:36:35+00:00","dateModified":"2024-07-18T13:57:13+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/promise-weekly-digest-nr-21\/"},"wordCount":308,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization"},"keywords":["AMR","Antibior\u00e9sistance","Antimicrobioal Resistance","OneHealth","PROMISE"],"articleSection":["Actualit\u00e9s","Actualit\u00e9s PPR Antibior\u00e9sistance","Bilans, rapports et recommandations"],"inLanguage":"en-GB"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/promise-weekly-digest-nr-21\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/promise-weekly-digest-nr-21\/","name":"PROMISE Weekly Digest Nr 21 - French\u00a0National ANTIBIOTIC RESISTANCE Portal","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website"},"datePublished":"2024-07-03T08:36:35+00:00","dateModified":"2024-07-18T13:57:13+00:00","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/promise-weekly-digest-nr-21\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/promise-weekly-digest-nr-21\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/promise-weekly-digest-nr-21\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Practical info &amp; communications","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/"},{"@type":"ListItem","position":3,"name":"News","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/"},{"@type":"ListItem","position":4,"name":"PROMISE Weekly Digest Nr 21"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/","name":"French\u00a0National ANTIBIOTIC RESISTANCE Portal","description":"INSERM - From science to health","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/3bec06f8a90e180a3ba8957cae88c700","name":"Kevin Gr\u00e9goire"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-16 10:48:01","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/29575"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/users\/280"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/comments?post=29575"}],"version-history":[{"count":2,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/29575\/revisions"}],"predecessor-version":[{"id":29583,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/29575\/revisions\/29583"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/media?parent=29575"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/categories?post=29575"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/tags?post=29575"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}